Stock AIMD AINOS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Ainos, Inc.

Equities

AIMD

US00902F3038

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-04 EDT 		5-day change 1st Jan Change
0.8151 USD -2.56% Intraday chart for Ainos, Inc. -23.10% -60.24%
05-15 Ainos to Start Clinical Trial of Potential Animal Drug for Oral Disease Treatment MT
05-15 Ainos, Inc. to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AINOS, INC. Stock Ainos, Inc.
 5.44M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.82B -
ARGENX SE Stock argenx SE
 22.48B -
GENMAB A/S Stock Genmab A/S
 18.32B
  1. Stock Market
  2. Equities
  3. AIMD Stock
  4. Charts Ainos, Inc.
  5. Sector Chart